Can People Without Viral Suppression Benefit From Cabenuva? - POZ


8/19/2022 12:00:00 AM2 years 8 months ago

Most people in a pilot program at a safety-net HIV clinic achieved viral suppression on the long-acting injectable regimen.

Long-acting Cabenuva (cabotegravir and rilpivirine) injections may be an option for people with HIV who are unable to achieve viral suppression due to challenges with treatment adherence, according t… [+8536 chars]

full article...